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Abstract: Introduction: There is little data on the
association of metabolic syndrome and health status in
Serbian men, so our intention was to investigate the
prevalence of the metabolic syndrome in men with no
history of diabetes or cardiovascular disease in New
Belgrade, Serbia; to determine which of the anthropo-
metric parameters (body mass index — BMI and waist
circumference — WC) is best for the evaluation of he-
alth risks in primary care, especially the risk factors for
metabolic syndrome.
Research Methods and Procedures: The study
involved 132healthy menages44.73 ±9.37 years.An-
thropometric values were measured in all the patients.
Blood pressure, blood biochemistry (high-density li-
poprotein-cholesterol, low-density lipoprotein-choles-
terol,triglycerides, bloodglucose)andanalysisoftheir
medical records were also done. Analysis of consis-
tency has been used in testing hypothesis.
Results: The sample consisted of 132 patients
with mean age 44.73 ± 9.37 years. The prevalence of
the metabolic syndrome was44.7%. Analysis ofconsi-
stence showed differences in the combined predictive
ability of anthropometric indicators and other factors
of MetS.
Conclusions:BMIandWCarethesimplemeasu-
res of adiposity most strongly associated with metabo-
lic abnormalities. Our findings suggest that WC can
not be used as a complementary measurement to iden-
tify health risks in any group of men.
Keywords:HealthRisk,Waistcircumference,Body
mass index, Metabolic syndrome.
INTRODUCTION
MetS is a group of related risk factors (metabolic
factors) that lead to atherosclerotic cardiovascular dis-
ease and type 2 diabetes. The dominant risk factors for
MetS are abdominal obesity and insulin resistance, ot-
her conditions that affect are: physical inactivity, ag-
ing, hormonal disorders (1, 2, 3).
It turned out that abdominal obesity accompany-
ing metabolic and cardiovascular disorders in the
MetS. This can be explained by varying the magnitude
of the enzymes involved in lipolysis, triglyceride syn-
thesis and secretion of adipokines in different parts of
the body fat. In addition to fat, triglycerides, ectopic
deposition in all tissues, especially the liver, muscle
and pancreatic ß-cells, where they can express their li-
potoxicity. This effect is manifested as hepatic steato-
sis, dysfunction and apoptosis of pancreatic ß-cells.
Besides lipotoxicity triglycerides lead to insulin resis-
tance in hepato-and myocytes (1, 2, 3).
In recent years, there has been increasing specula-
tion which measure of overweight and obesity is the
best to discriminate those individuals who are at incre-
asedcardiovascular andmetabolic risk.Population-ba-
sed,cross-sectional, andprospective studiesclearlyes-
tablish that body mass index (BMI) and waist circum-
ference (WC) are predictors of cardiovascular disease
and type 2 diabetes (1–5). Body mass index (BMI) is
usedbytheWorldHealthOrganization todefinesever-
ity of overweight and obesity across populations (1, 2,
3). The latter observation is consistent with a large
body of evidence implicating abdominal obesity, in
particular visceral fat, in the pathogenesis of numerous
metabolic risk factors. But increasingly, measure of
central adiposity, waist circumference (WC), has been
adopted as more accurate predictor of obesity-related
cardiovascular risk and have replaced BMI in several
definitions for clinical diagnosis of metabolic syndro-
me (1, 2, 3).
In peoplewho havenormal weight (BMI<25 kg/m
2)
and in overweight individuals (BMI = 25.0–29.9 kg/m
2)
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with increasing waist circumference. If a BMI  30
kg/m
2, it indicates the presence of central obesity and
WC is not need to be measured (5, 6, 7).
There is no data on the prevalence of metabolic
syndrome among middle aged Serbian men. It is very
importanttosetupastudyonthehealthmenwitharisk
of metabolic syndrome. The present study aimed to as-
sess the metabolic syndrome among men in New Bel-
grade, Serbia and to determine which of the anthropo-
metric parameters (body mass index and waist circum-
ference) is best for the evaluation of the risk factors for
metabolic syndrome in men in primary care.
The null hypothesis is that the waist circumferen-
ceisnotthebestanthropometric predictorofmetabolic
syndrome in men.
MATERIALAND METHODS
This cross-sectional study was performed in the
Preventive center “New Belgrade”, in period Septem-
ber–October 2007. The study was conducted on 132
men,meanage44.73±9.37years,whowereonaregu-
lar systematic review. After the analysis of medical re-
cords,weexcludedexamineeswithdiabetesandCVD.
The participants gave informed consent before ta-
king part and the authors followed the World Medical
Association’s Declaration of Helsinki.
In the examined groups clinical examinations we-
re performed including blood pressure measurement,
as well as blood biochemistry, and evaluation of an-
thropometric parameters, nutritional status, and meta-
bolic risk factors.
Anthropometric measurement of waist circumfer-
ence was taken for each subject as half way between
costalarchandiliaccrestonthemedianaxillary line.A
ribbon madeofnon-stretching plastic wasused, placed
parallel to the base, with a patient in an upright posi-
tion, with arms by the body. The measurements were
recorded in centimeters.
Height and weight were measured by anthropo-
metry and medical scales with sliding weight accord-
ing to standard procedure Š8¹. From these values, BMI
was calculated as recommended by the World Health
Organization (WHO). According to the nutritional sta-
tusthesubjectsweredivided intothreegroups:group1
— optimally nourished (BMI = 18.5 to 24.9 kg/m
2),
group 2 — overweight (BMI = 25.0 to 29.9 kg/m
2);
group 3 — obese (BMI  30.0 kg/m
2).
Blood pressure was measured in a sitting position
on patient’s left hand, taking the average of three mea-
surements, according to the standard procedure recom-
mendedbytheAHA(AmericanHeartAssociation)(8).
Evaluation of metabolic risk factors included the
determination of fasting blood glucose, total choleste-
rol, LDL-C, HDL-C and triglycerides. Avenous blood
sample was collected from each respondent who came
in the morning after 8 to 12 hours an overnight fasting.
Blood glucose concentration was determined by the
oxidation of glucose (glucose analyzer Beckman Coul-
ter).Triglycerides,totalcholesterol,HDL-CandLDL-C
were determined by chromatography (accessories Bo-
eringher Mannheim). Reference values for serum lipid
profile and fasting glucose were determined on the ba-
sis of IDF diagnostic criteria for MetS (1, 2, 3).
Definition of metabolic syndrome
TheInternational Diabetes Federation (IDF)diag-
nostic criteria for metabolic syndrome (1, 2, 3) are li-
sted as following:
WC higher than 80 cm in women or WC higher
than 94 cm in men plus 2 or more of the following:
a. Low HDL cholesterol with values equaling or
lower than 1.03 mmol/L for men and 1.29 mmol/L for
women or under treatment;
b. Hypertriglyceridemia with values higher than
1.7 mmol/L or under treatment;
c. Arterial hypertension with values equaling or
higher than 130/85 mm Hg, or under treatment;
d. Fasting hyperglycemia with values equaling or
higher than 5.6 mmol/L, or under treatment.
All statistical analysis were performed using the
Statistical Package for Social Science (SPSS for Win-
dows) and StatCalc of the EPI-INFOsoftware package
in version 6.0. All data were expressed as mean value
(Xsr), standard deviation (SD), absolute frequencies
(n) and the index structure (%). Comparison of mean
values of numerical parameters by BMI category was
performed by analysis of variance (ANOVA)and Dun-
net post hoc test. Comparison of the representation of
attribute characteristics between groups was perfor-
med Mantel-Haenszel chi square test or Fisher’s exact
probability test of the null hypothesis (Fisher exact
test) when any of the expected frequency characteris-
tics was lower than five. Relationship between the val-
ues of different characteristics was evaluated by calcu-
lating Pearsonlinearcorrelation coefficient(r).Testing
the statistical significance ofthe correlation coefficient
was performed using the Student t test. Effect of some
factors on the development of metabolic syndrome and
assessment of risk for consequences of metabolic syn-
drome was done by logistic regression analysis. Calcu-
lated values are approximate relative risk (odds ratio —
OR) and their 95% confidence intervals. Assessment of
statisticalsignificanceORvalueswasperformedbycal-
culating the Wald values. The factors for the univariate
logisticregressionanalysis,thatshowedexertsasignifi-
cant influence on the metabolic syndrome, were inclu-
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hod step by step backwards (Backward Wald) from the
multivariatemodelwereexcludedallthosefactorswho-
se impact was not statistically significant.
All factors of the metabolic syndrome may be ob-
served as a dichotomous variable and we can form an
additive scale The analysis of the value of this scale can
be determined, what factors, in addition to an increased
waist circumference, contribute most to the occurrence
of metabolic syndrome, based on the calculation of
Cronbach’s alpha coefficient of internal consistency.
All P values were based on two-sided tests with a
significance level of 0.05.
RESULTS
Characteristics of examinees
The study included 132 men, who were on a regu-
lar systematic review. The mean age was 44.73 ± 9.37
years (range 35–54 years, median 44.5 years). Basic
characteristics of study group and the level of metabo-
lic risk components are shown in Table 1.
The prevalence of the metabolic syndrome in
study group, according to the IDF was 44.7%. Of all
men, most were overweight; 68.9% had a waist cir-
cumference equaling or higher than 94 cm, 67.4% had
highbloodpressure;55.3%hadhighvalueoftriglycer-
ides.Lessthan50%ofstudysubjectshadabnormalva-
lues of another metabolic risk factors (Table 2).
Normal-weight subjects were younger; had signi-
ficantly lower blood glucose and triglycerides, than over-
weight and obese men (p < 0.05). HDL-C in normal-
-weight men was higher than in other patients (p < 0.05).
WCwassignificantly increased inparallel withincrea-
sing BMI (p < 0.001) (Table 3).
Among subjects with normal BMI, only 5 men had
WC  94 cm, but 97.1 % obese men had WC  94 cm.
Onlyonemale(4.8%)withnormalweighthadmetabo-
lic syndrome, while the number of people with this
syndrome significantly increases with increasing BMI.
MetS had 35 (46.1%) overweight and 23 (65.7%) obe-
se subjects. If we look at the prevalence of all compo-
nents of metabolic syndrome by BMI categories, it is
evident that the only statistically significant increase
were in WC and triglycerides (Tables 4).
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Variable Mean ± SD
Ages (years) 44.73 ± 9.37
Waist circumference (cm) 101.43 ± 12.38
Body mass index (kg/m
2) 27.79 ± 3.63
Sistolic blood pressure (mmHg) 131.25 ± 15.79
Diastolic blood pressure (mmHg) 85.00 ± 11.41
Blood glucosa (mmol/l) 5.64 ± 1.36
HDL cholesterol (mmol/l) 1.40 ± 0.32
Triglycerides (mmol/l) 2.30 ± 1.20
Table 1. Anthropometric indices, blood pressure,
blood glucose and serum lipid levels in study subjects
(Mean ± SD)
Table 2. Prevalence of MetS and the components
of MetS in study subjects
Variable n (%)
BMI < 25 kg/m
2 21 (15.9%)
BMI = 25–29.9 kg/m
2 76 (57.6%)
BMI  30 kg/m
2 35 (26.5%)
WC  94 cm 91 (68.9%)
High blood presure  130/85 mmHg 89 (67.4%)
Blood glucosa  5.6 mmol/l 43 (32.6%)
HDL cholesterol < 1.04 mmol/l 6 (4.5%)
Triglycerides  1.7 mmol/l 73 (55.3%)
METABOLIC SYNDROME 59 (44.7%)
Variable Normal weight
(n = 21)
Overweight
(n = 76)
Obesity
(n = 35)
ANOVA i
Dunnet’s test)
Ages (years) 40.95 ± 9.80 45.64 ± 9.41 45.00 ± 8.69 Ns
Waist circumference (cm) 89.33 ± 5.77 98.87 ± 8.41 114.26 ± 11.86 A‡, B‡, C‡
Sistolic blood pressure (mmHg) 127.86 ± 23.00 130.33 ± 13.74 135.29 ± 14.40 Ns
Diastolic blood pressure (mmHg) 82.14 ± 13.47 84.67 ± 10.56 87.43 ± 11.72 Ns
Blood glucosa (mmol/l) 5.14 ± 0.38 5.64 ± 1.32 5.94 ± 1.71 A*, B*
HDL cholesterol (mmol/l) 1.59 ± 0.41 1.39 ± 0.32 1.33 ± 0.23 B*
Triglycerides (mmol/l) 1.65 ± 0.81 2.38 ± 1.20 2.50 ± 1.30 A†, B*
A—optimalweightvsoverweight;B—optimalweightvsobese;C—overweightvsobese;*—p<0.05;†—p<0.01;
‡ — p < 0.001; ns — no significant difference
Table 3. Average values of ages, WC, BP, BG, HDL-C and triglycerides
of study subjects according to BMI categoryRelationship between
anthropometric indices and non
adipose metabolic risk factors
The linear correlation coefficients were estimated
between anthropometric indices and components of
MetS according to the criteria of IDF (Table 5). BMI
wasshowedasignificantcorrelationwithbodyweight,
blood pressure, blood glucose and triglyceride levels,
while negatively correlated with HDL cholesterol. WC
values were significantly associated only with the valu-
esofbodyweight(r=0.58,p<0.01)andBMI(r=0.78,
p < 0.01) (Table5).
The influence
of certain factors on the MetS
ChangesinthevalueofthecoefficientCronbach-
were showen that the most important factors of meta-
bolic syndrome inmenwerehigher levels oftriglyceri-
des (from 0.40 to 0.15), the presence of hypertension
(form 0.40 to 033) and abnormal glucose regulation
(form0.40 to033); whereasincreased waistcircumfer-
ence and lower levels of HDL cholesterol were of less
importance (no changes in the value of the coefficient
Cronbach-) (Table 6).
Univariate logistic regression analysis showed
that with each year of age the risk of metabolic syndro-
mesignificantly increasedby6%(OR=1.06,95%CI).
Increasing values of body weight and BMI for one me-
asurement units also lead to increased risk. Other fac-
tors did not show a significant influence on the devel-
opment of the metabolic syndrome in the sample (Ta-
ble 7).
When in the regression model as independent va-
riables were included all the factors, which in the uni-
variate logistic regression analysis wereshown asigni-
ficant effect on the level of error margin of less than
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Variable
Normal
weight
(n = 74)
Overweight
(n = 40)
Obesity
(n = 18)
Statistical
significance
(Mantel-Haenszel

2
or Fisher’s test)
WC  94 cm 5 (23.8%) 52 (68.4%) 34 (97.1%) A‡, B‡, C†
High blood pressure  130/85 mmHg 11 (52.4%) 52 (68.4%) 26 (74.3%) Ns
Blood glucosa  5.6 mmol/l 3 (14.3%) 25 (32.9%) 15 (42.9%) B*
HDL cholesterol < 1.29 (f) – 5 (6.6%) 1 (2.9%) Ns
Triglycerides  1.7mmol/l 4 (19.0%) 49 (64.5%) 20 (57.1%) A‡, B†
METABOLIC SYNDROME 1 (4.8%) 35 (46.1%) 23 (65.7%) A†, B‡
A—optimalweightvsoverweight;B—optimalweightvsobese;C—overweightvsobese;*—p<0.05;†—p<0.01;
‡ — p < 0.001; ns — no significant difference
Table 4. Prevalence of MetS and it’s individual features stratified by BMI category
Table 5. Correlation coefficients between anthropometric indices
and other components for MetS in study subjects
Variable Body
height
Body
mass WC BMI SBP DBP Blood
glucose HDL-C Trigly-
cerides
Ages –0.39† –0.12 0.17 0.12 0.05 –0.01 0.29† 0.05 0.02
Body height 0.57† –0.07 0.07 0.08 0.12 0.01 –0.08 0.05
Body mass 0.58† 0.83† 0.19* 0.23* 0.20* –0.25† 0.24†
WC 0.78† 0.03 0.01 0.11 –0.17 0.13
BMI 0.19* 0.20* 0.26† –0.25† 0.26†
SBP 0.80† 0.08 –0.05 0.30†
DBP 0.07 –0.13 0.30†
Blood glucose –0.06 0.09
HDL-C –0.24†
* — p < 0.05; † — p < 0.01.10% (p < 0.1), the risk of metabolic syndrome was in-
creasedsignificantly witheachyearofageandincreas-
ing BMI values of 1. Table 8 shows how to modify the
risk of metabolic syndrome with each year of age and
increasing BMI values.
DISCUSSION
This study comprising 132 adult men aged 35
years and over aimed prevalence of MetS and to com-
parativewhichoftheanthropometric parameters(body
mass index and/or waist circumference) is best for the
evaluation of the risk factors for metabolic syndrome.
Prevalence of MetS
It has been estimated that 20–25% of the world
population has MetS (1). In our study, metabolic syn-
drome was diagnosed in 59 men (44.7%). Ardern et al.
showed that 17% of men in Canada have MetS, while
the prevalence MetS in the U.S. among men adults is
24,0% (5, 9). The Sofia Metabolic Syndrome (SMS)
study reported preliminary data on high prevalence of
the components of MetS among the citizens of Sofia in
both sexes, and a very high percentage of unknown
type 2 diabetes, hypertension and hyperlipidemia, and
in some countries, like Greece and USAsimilar preva-
lence was also observed for both sexes; in Turkey, In-
dia, Iran, African Americans and Mexican Americans
women were reported to be much more frequently af-
fected, whereas in France and Australia the MetS was
found to be more common among men (10). It was re-
ported that non-diabetic subjects under 40 years of age
had an MetS prevalence of 14–41% (11).
Association of MetS
components and MetS
Distribution of body fat has a direct impact on the
occurrence of metabolic disorders that lead to the met-
abolic syndrome (1, 2, 3). WC is always the main com-
ponent of the diagnostic criteria for the metabolic syn-
drome,andalsoincreasinglybeingproposedasabetter
predictor of cardiovascular risk than BMI (1, 5).
In people who are optimally nourished and overwe-
ight prevalence of metabolic syndrome increases with in-
creasing waist circumference. If BMI  30 kg/m
2,i tp o -
intstotheexistenceofcentralobesity(3,5,6,7).Thepre-
valence of abdominal obesity in our study was 68.9%. In
the group of optimal weight men the prevalence of abdo-
minal obesity was 23.8%. In the obese group, 68.4% of
men had increased WC, while the abdominal obesity oc-
curs in 97.1% of men. In a study conducted by Ardren
andcolleagues65%ofobesemenhadvaluesgreaterthan
the WC limit values; in the group of overweight 13% of
men had high levels of WC (5). Janssen et al have obtai-
ned similar findings: increased levels of WC in the opti-
mal weight category had 1.0% of men, in the overweight
group 27.6% of men, while the prevalence of abdominal
obesity in the obese group was 84.8% (12). These data
confirm previous studies and show that WC does not
need to be measured if BMI  30 kg/m
2 ( 5 ,6 ,7 ,1 3 ) .
The analysis of the frequency of certain compo-
nents ofMetS,according tothedegree ofobesity inthe
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Table 6. Analysis of the consistency factor of the metabolic syndrome in study group (Cronbach- coefficient)
The steps in the assessment of internal
consistency Average value of the scale Cronbach coefficient
All factors included 2.29 0.40
Factors excluded from the scala:
High blood pressure 1.61 0.33
Impaired glycemic control 1.96 0.33
High levels of triglycerides 1.74 0.15
Low HDL cholesterol 2.24 0.42
High WC 1.60 0.43
Table 7. The influence of certain factors on the
development of the metabolic syndrome in men
(Univariate logistic regression analysis)
Factors p OR 95% CI
Ages 0.002 1.06 1.02–1.10
Body height ns 1.01 0.96–1.05
Body mass < 0.001 1.07 1.03–1.11
BMI < 0.001 1.46 1.25–1.71
Table 8. The influence of certain factors on the
development of the metabolic syndrome in men
(Multivariate logistic regression analysis)
factors p OR 95% CI
Ages 0.006 1.07 1.02–1.11
BMI < 0.001 1.47 1.25–1.73examined men, found that individuals with normal we-
ight commonly occurring hypertension (52.4%); in the
overweight were OS  94 cm (68.4%), elevated serum
triglycerides (64.5%) and high blood pressure (68.4%);
while in the group of obese were waist circumference
(97.1%), hypertension (74.3%) and elevated serum
triglycerides (57.1%). Those results are in agreement
with previously reported data (14).
Analysis consistency factor of metabolic syndro-
me found that different components influence the oc-
currence ofMetSinmen:high blood pressure; high tri-
glycerides, high blood glucose, which is consistent
with the expected sexual characteristics, and data from
the literature (5).
Ardern et al., in their study showed that the most
important factors of MetS in men are high levels of tri-
glycerides, highblood pressureandlowHDLcholeste-
rol (6). It is now well established that WC remains a
ignificant predictor of type 2 diabetes and cardiovas -
cular disease after control for BMI in both men and
women. It is often suggested that the ability of WC to
predict health risk beyond that predicted by BMI alone
is explained by the ability of WC to act as a surrogate
for abdominal fat (4). However, it is also observed that
the values of WC and BMI as predictors of metabolic
abnormalities and clinical manifestations ofMetSvary
in different populations (ethnic groups) (15).
CorrelationbetweenWC,BMIandMetS
In the examined men WC values show a signifi-
cant correlation with values of body weight and BMI,
while BMI was showed a significant correlation with
body weight, blood pressure, blood glucose and tri-
glyceride levels, and negatively correlated with HDL.
Increasing values of BMI for one measurement units
lead to increased risk for MetS and cardiovascular dis-
ease.However,studies have shownthat both anthropo-
metricfactorscorrelatedwithall10riskfactorsforcar-
diovascular disease in young adults of both sexes, and
intheelderlymentheseanthropometricfactorsarecor-
related with 8 of 10 risk factors, but whether BMI or
WC is a better predictor of cardiovascular (metabolic)
risk factors depend on age, as metabolic syndrome de-
pendsontheagerangeasshowedinourandotherstud-
ies (1–3, 5, 11,16).
CONCLUSION
Results of our study show that high WC (68.9%)
and MetS (44.7%) are present in a high percentage in
the study group. According to the coefficient Cron-
bach-, WC is not the best indicator of metabolic he-
alth risk in men. But, based on other our results and da-
ta from the literature, measurement of waist circumfer-
encebyBMIcategoriescanpointtomenwithanincre-
ased risk of development of metabolic disorder.
List of abbreviations:
BMI — body mass index
CVD — cardio-vascular disease
DM 2 — type 2 diabetes mellitus
IDF — International Diabetes Federation
LDL— low density lipoproteins
HDL— high density lipoproteins
MetS — metabolic syndrome
WC — waist circumferences
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Sa`etak
PROCENAZDRAVSTVENOG RIZIKANAOSNOVU ANTROPOMETRIJSKIH
POKAZATELJAKOD MU[KARACAU NOVOM BEOGRADU
Stankovi} Veroslava
1, Nikoli} Maja
2
1 Visoka zdravstvena {kola strukovnih studija u Beogradu, Beograd, Srbija
2 Medicinski fakultet u Ni{u, Univerzitet u Ni{u, Srbija
Uvod: Veoma mali broj istra`ivanja je ra|eno u
Srbiji u cilju povezivanja zdravstvenog statusa i meta-
boli~kog sindroma kod mu{karaca, tako da je na{ cilj
bio da se ispita u~estalost metaboli~kog sindroma kod
mu{karaca bez istoriju dijabetesa ili kardiovaskularnih
bolesti u Novom Beogradu, u Srbiji, da se utvrdi koji
od antropometrijskih parametara (indeks telesne mase
— ITM i obim struka — OS) je najbolje za procena ri-
zika po zdravlje u primarnoj zdravstvenoj za{titi, po-
sebno faktora rizika za metaboli~ki sindrom.
Istra`iva~ke metode i postupci : Studija je obu-
hvatila132zdravihmu{karacauzrasta44,73±9,37go-
dina. Radjena su antropometrijska merenja, kao i me-
renja krvnog pritiska, biohemijske analize (HDL,
LDL,trigliceridi, {e}erukrvi)ianalizanjihovih zdrav-
stvenih kartona. Analiza konzistentnosti je kori{}ena
za testiranje hipoteze.
Rezultati: Uzorak su ~inili 132 ispitanika pro-
se~nestarosti44,73 ±9,37godina. Prevalenca metabo-
li~kog sindroma bila je 44,7 %. Analiza konzistentno-REFERENCES
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sti je pokazala razlike u mogu}nostima predvi|anja na
osnovu antropometrijskih pokazatelja i ostalih faktora
MetS.
Zaklju~ci: ITM i OS su jednostavne metode za
procenu gojaznosti koje su povezane sa metaboli~kim
poreme}ajima. rizika. Na{i rezultati ukazuju da se OS
ne mo`e koristiti kao komplementarno merenje u iden-
tifikaciji zdravstvenih za bilo koju grupu mu{karaca.
Klju~ne re~i: zdravstveni rizik, obim struka, in-
deks telesne mase, metaboli~ki sindrom.
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